Lensar is the leading manufacturer of next-generation femtosecond laser technology for refractive cataract eye surgery. With a mission to meet the dynamic needs of surgeons and their patients, Lensar has developed innovative technology and provided surgeons with six software updates in just two years, resulting in more precise astigmatism management and improved refractive outcomes. Lensar's products and services ensure that surgeons can deliver the best medicine to their patients and improve their practice's efficiency.

One key aspect of Lensar's success is their prestigious Medical Advisory Board, which guides their industry-leading innovation. The board includes renowned ophthalmologists such as Dr. Carlos Buznego, recognized for his expertise in LASIK, laser cataract, and micro-invasive glaucoma surgery.

Another member is Dr. Warren Hill, known for his work on IOL power selection and widely recognized as an expert in the field. Dr.

Mitchell A. Jackson, specializing in cataract and refractive surgery, and Dr. Mark Packer, an internationally recognized leader in ophthalmology, are also part of the board.

Dr. Gregory D. Parkhurst, the founder and Physician-CEO of Parkhurst NuVision, brings extensive experience in refractive surgery to the team.

Lensar's commitment to excellence and collaboration with renowned experts make them a trusted brand for surgeons and patients alike